Recent Articles from GlobeNewswire
By Bombardier Inc. · Via GlobeNewswire · November 6, 2025
New York, NY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Tailwind 2.0 Acquisition Corp. (the “Company”) announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit on November 6, 2025. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “TDWDU” beginning November 7, 2025. Each unit consists of one Class A ordinary share and one right to receive one tenth of a Class A ordinary share upon the consummation of the Company’s initial business combination. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and rights will be listed on the Nasdaq Global Market under the symbols “TDWD” and “TDWDR,” respectively. The offering is expected to close on November 10, 2025, subject to customary closing conditions.
By Tailwind 2.0 Acquisition Corp. · Via GlobeNewswire · November 6, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) for violations of the federal securities laws on behalf of all persons and entities who purchased or acquired Six Flags common stock pursuant or traceable to the Company’s registration statement and prospectus (“Registration Statement”) issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair, L.P. and their affiliates and subsidiaries (the “Merger”).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · November 6, 2025
To Replace Existing $65 Million Encina Credit Facility at Lower Spreads
By Saratoga Investment Corp · Via GlobeNewswire · November 6, 2025
LAS VEGAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Think you’re a smart bettor?
By Bookmakers Review · Via GlobeNewswire · November 6, 2025
(Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from unaudited interim consolidated financial statements for the three and nine months ended September 30, 2025 prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS Accounting Standards") applicable to the preparation of interim financial statements, including International Accounting Standard 34 Interim Financial Reporting. This news release contains certain non-GAAP and other financial measures, including underwriting profit (loss), adjusted operating income (loss), gross premiums written, net premiums written, combined ratio (both discounted and undiscounted), book value per basic share, total debt to total capital ratio excluding non-insurance companies and excess (deficiency) of fair value over carrying value, that do not have a prescribed meaning under IFRS Accounting Standards and may not be comparable to similar financial measures presented by other issuers. See "Glossary of non-GAAP and other financial measures" at the end of this news release and in the company's Interim Report for the three and nine months ended September 30, 2025 for further details.)
By Fairfax Financial Holdings Limited · Via GlobeNewswire · November 6, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · November 6, 2025
Adjusted EBITDA loss of $184 million and Net Loss of $216 million
By Interfor Corporation · Via GlobeNewswire · November 6, 2025
Grand Cayman, Cayman Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Crown Reserve Acquisition Corp. I (the “Company”) announced today the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and begin trading tomorrow, November 7, 2025, under the ticker symbol “CRACU.” Each unit consists of one Class A ordinary share, one-half of one redeemable warrant, and one right (the “Share Right”) to receive one-fifth (1/5) of one Class A ordinary share upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable. No fractional shares will be issued in connection with the exchange of Share Rights. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities comprising the units begin separate trading, we expect that the Class A ordinary shares, warrants, and Share Rights will be listed on the Nasdaq under the symbols “CRAC”, “CRACW”, and “CRACR”, respectively. The offering is expected to close on November 10, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments, if any.
By CROWN RESERVE ACQUISITION CORP. I · Via GlobeNewswire · November 6, 2025
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual program, conducted by leading independent market intelligence organization BioTech Breakthrough, recognizes innovative life sciences and biotechnology companies, products, and services worldwide. This year’s competition drew thousands of nominations from more than 15 countries.
By Cytek Biosciences, Inc. · Via GlobeNewswire · November 6, 2025
MEXICO CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Grupo Aeromexico S.A.B. de C.V. (“Aeromexico”) reports its October 2025 operational results:
By Grupo Aeroméxico, S.A.B. de C.V. · Via GlobeNewswire · November 6, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against James Hardie Industries plc. (“James Hardie” or the “Company”) (NYSE: JHX) for violations of the federal securities laws on behalf of investors who purchased or acquired James Hardie securities between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · November 6, 2025
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end
By BioAge Labs, Inc. · Via GlobeNewswire · November 6, 2025
TEL AVIV, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced it will release financial results for the third quarter ended September 30, 2025, before the market opens on Friday, November 14, 2025. Management will host a webcast and conference call at 8:30 a.m. EDT on the same day to review results.
By GAUZY LTD · Via GlobeNewswire · November 6, 2025
FALLS CHURCH, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) announces that its board of directors has elected John Greene corporate vice president and chief financial officer (CFO), effective Jan. 7, 2026. He will report to Kathy Warden, chair, chief executive officer and president.
By Northrop Grumman Corporation · Via GlobeNewswire · November 6, 2025
Quarter Sales of $203.8 million, up 62% from a year earlier,
By Power Solutions International, Inc. · Via GlobeNewswire · November 6, 2025
CLEVELAND, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 30,000,000 shares of its common stock, par value $0.01 per share. All 30,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement.
By Sotera Health Services, LLC · Via GlobeNewswire · November 6, 2025
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Today, Opendoor Technologies Inc. (Nasdaq: OPEN) (“Opendoor” or the “Company”) announced a special dividend distribution of warrants to holders of the Company’s common stock as of 5:00 p.m. New York City time on November 18, 2025 (the “Record Date”). The goal is simple: if management gets performance-based upside, shareholders should too - these warrants help achieve that.
By Opendoor Technologies Inc. · Via GlobeNewswire · November 6, 2025
BALTIMORE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported financial results for third quarter 2025.(1)
By MarketWise LLC · Via GlobeNewswire · November 6, 2025
Funding boosts service dog programs and college scholarships, honoring National Veterans and Military Families Month
By Pritzker Military Foundation · Via GlobeNewswire · November 6, 2025
ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 4, 2025, the Company granted 23 new employees 77,650 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan.
By Esperion Therapeutics, Inc. · Via GlobeNewswire · November 6, 2025
Selected Highlights
By Mercer International Inc. · Via GlobeNewswire · November 6, 2025
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025, at 4:00 pm ET in New York, NY.
By MacroGenics, Inc. · Via GlobeNewswire · November 6, 2025
SOUTH BEND, Ind., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) today announced that its Board of Directors declared a cash dividend on its common stock in the amount of $0.16 per share (the “Dividend”). The Dividend will be payable in cash on December 30, 2025, to stockholders of record as of the close of business on December 16, 2025.
By Strawberry Fields REIT · Via GlobeNewswire · November 6, 2025
All dollar references are in U.S. dollars, unless noted otherwise.
By Brookfield Property Partners L.P. · Via GlobeNewswire · November 6, 2025
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers –
By Shattuck Labs, Inc. · Via GlobeNewswire · November 6, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
By Teladoc Health, Inc. · Via GlobeNewswire · November 6, 2025
Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $22.2 million, or $.78 per share, in the third quarter of 2025 compared to net income of $57.5 million, or $2.01 per share, in the third quarter of 2024. For the first nine months of 2025, Valhi reported a net loss attributable to Valhi stockholders of $4.4 million, or $.15 per share, compared to net income of $85.2 million, or $2.99 per share, in the first nine months of 2024. Net income attributable to Valhi stockholders decreased in the third quarter and first nine months of 2025 as compared to the same periods in 2024 primarily due to lower operating results from the Chemicals Segment, a third quarter non-cash gain in 2024 related to the Chemicals Segment acquisition of the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) discussed below and an increase in the Company’s tax expense due to legislation enacted in Germany during the third quarter of 2025, which resulted in a non-cash deferred income tax expense of $19.3 million ($12.8 million, or $.45 per share, net of noncontrolling interest).
By Valhi, Inc. · Via GlobeNewswire · November 6, 2025
Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on December 18, 2025 to stockholders of record at the close of business on November 21, 2025.
By Valhi, Inc. · Via GlobeNewswire · November 6, 2025
MISSION, Kan., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Family Features) Stress and parenting go hand in hand, but during the holiday season, many parents find their stress levels rising to new heights. Between coordinating schedules, shopping, traveling and managing children’s expectations – plus the disruption to the school routine that everyone had finally settled into – the season can feel more like mayhem than merry.
By Family Features · Via GlobeNewswire · November 6, 2025
Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- NL Industries, Inc. (NYSE: NL) today reported a net loss attributable to NL stockholders of $7.8 million, or $.16 per share, in the third quarter of 2025 compared to net income attributable to NL stockholders of $36.0 million, or $.74 per share, in the third quarter of 2024. NL results include an unrealized loss of $.5 million in the third quarter of 2025 related to the change in value of marketable equity securities compared to an unrealized gain of $18.6 million in the third quarter of 2024. For the first nine months of 2025, NL reported a net loss attributable to NL stockholders of $6.8 million, or $.14 per share, compared to net income attributable to NL stockholders of $50.7 million, or $1.04 per share, for the first nine months of 2024. NL results include an unrealized loss of $9.1 million in the first nine months of 2025 related to the change in value of marketable equity securities compared to a $21.8 million unrealized gain in the first nine months of 2024.
By NL Industries · Via GlobeNewswire · November 6, 2025
Jim Hannon stepping down as CEO; Mike Gordon appointed Executive Chair and to become CEO in Q1 2026
By Altus Group Limited · Via GlobeNewswire · November 6, 2025
Melville, NY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Canon Inc., the parent company of Canon U.S.A., Inc., a leader in digital imaging solutions, announced that Canon's 3D VR lens for APS-C cameras, the RF-S3.9mm F3.5 STM DUAL FISHEYE, has won the Gold Award, which is the highest honor at the 2025 International Design Excellence Awards (IDEA), hosted by the Industrial Designers Society of America. This marks the first time Canon has won a Gold Award at IDEA.
By Canon U.S.A., Inc. · Via GlobeNewswire · November 6, 2025
Steady Recurring Revenue* Growth and Adjusted EBITDA Margin* Expansion
By Altus Group Limited · Via GlobeNewswire · November 6, 2025
Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39
By AMN Healthcare Services Inc · Via GlobeNewswire · November 6, 2025
SAN ANTONIO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (Nasdaq: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced results for its third quarter ended September 30, 2025.
By Rackspace US, Inc. · Via GlobeNewswire · November 6, 2025
CINCINNATI, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The E.W. Scripps Company (NASDAQ: SSP) delivered $526 million in revenue for the third quarter of 2025. Loss attributable to the shareholders of Scripps was $49 million or 55 cents per share.
By E.W. Scripps Company (The) · Via GlobeNewswire · November 6, 2025
Updates Full Year 2025 Financial Guidance
By Certara · Via GlobeNewswire · November 6, 2025
BELLINGHAM, Wash., Nov. 06, 2025 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended September 30, 2025.
By eXp World Holdings, Inc. · Via GlobeNewswire · November 6, 2025
Gross margin decreased 400 basis points year-over-year to 39.7%Reported net loss of $4 million, adjusted EBITDA1 of $1.4 millionNet sales of $81.6 million
By Farmer Bros. Co. · Via GlobeNewswire · November 6, 2025
AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025.
By Globus Medical · Via GlobeNewswire · November 6, 2025
Increased Quarterly Sales 3% and Adjusted EBITDA 15%Adventure Reported Sales up 16%Apparel Sales at Outdoor up 29%
By Clarus Corporation · Via GlobeNewswire · November 6, 2025
SOUTH BEND, Ind., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) reported today its operating results for the quarter ended September 30, 2025.
By Strawberry Fields REIT · Via GlobeNewswire · November 6, 2025
BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced its third quarter 2025 financial results. The Company also posted a third quarter 2025 business update and a slide presentation on the Investor Relations section of its website at investors.draftkings.com.
By DK Crown Holdings Inc. · Via GlobeNewswire · November 6, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended September 30, 2025.
By Prospect Capital Corporation · Via GlobeNewswire · November 6, 2025
Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- November 6, 2025…Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $37.0 million, or $.32 per share, in the third quarter of 2025 compared to net income of $71.8 million, or $.62 per share, in the third quarter of 2024. For the first nine months of 2025, Kronos Worldwide reported a net loss of $28.1 million, or $.24 per share, compared to net income of $99.4 million, or $.86 per share, in the first nine months of 2024. Net loss increased in the third quarter and first nine months of 2025 due to legislation enacted in Germany during the third quarter of 2025, which included a reduction of the corporate tax rate from 15% by one percentage point annually for five years, reaching 10% in 2032. As a result, we recorded a non-cash deferred income tax expense of $19.3 million ($.17 per share) to reflect the impact of the rate reduction on our net German deferred tax asset. Our net loss for the three and nine months ended September 30, 2025 also includes a non-cash gain of $4.6 million ($3.6 million, or $.03 per share, net of income tax expense) resulting from a remeasurement of the earn-out liability initially recorded in connection with our acquisition of our joint venture, as discussed below. Net income for the three and nine months ended September 30, 2024 includes the recognition of a non-cash gain of $64.5 million ($50.9 million, or $.44 per share, net of income tax expense) associated with the remeasurement of our investment in our joint venture, as discussed below. Income from operations decreased in the third quarter of 2025 as compared to the third quarter of 2024 primarily due to lower production volumes resulting in lower absorption of our fixed production costs and lower average TiO2 selling prices. Income from operations for the first nine months of 2025 was lower than income from operations for the first nine months of 2024 primarily due to lower production volumes resulting in lower absorption of our fixed production costs, lower average TiO2 selling prices and higher distribution and warehousing costs incurred primarily in the first quarter of 2025 to position finished goods products inventory in the U.S. in response to anticipated U.S federal government tariff announcements and an overall increase in finished goods inventory in 2025 compared to 2024. Comparability of our results was also impacted by the effects of changes in currency exchange rates. As previously reported, effective July 16, 2024, we acquired the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) previously held by Venator Investments, Ltd. Prior to the acquisition, we held a 50% joint venture interest in LPC. Following the acquisition, LPC became a wholly-owned subsidiary of ours. We accounted for the acquisition as a business combination. The results of operations of LPC have been included in our results of operations beginning as of the acquisition date.
By Kronos Worldwide · Via GlobeNewswire · November 6, 2025
– CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer –
By Coherus Oncology, Inc. · Via GlobeNewswire · November 6, 2025
New capability to provide tailored and coordinated care informed by behavioral insights
By Omada Health, Inc. · Via GlobeNewswire · November 6, 2025
Revenue of $68 million, up 49%; 53% Member GrowthSignificant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDAAnnounces New GLP-1 Prescribing Offering
By Omada Health, Inc. · Via GlobeNewswire · November 6, 2025
New CEO Kaz Nejatian commits to return the Company to profitability, accelerating transactions, rescaling while leveraging the existing cost structure and launching new AI-driven products to power the future of homeownership
By Opendoor Technologies Inc. · Via GlobeNewswire · November 6, 2025
~ Board of Directors Has Approved an Annual Cash Dividend of $0.20 Per Share ~
By Abacus Global Management · Via GlobeNewswire · November 6, 2025
CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) intends to release third quarter results on November 13, 2025 after market close. A conference call and webcast will be held at 9:30 am MT (11:30 am ET) on Friday, November 14, 2025.
By Freehold Royalties Ltd. · Via GlobeNewswire · November 6, 2025
Reports 50.0% Increase in Total Investment Income and 94.2% in Net Investment Income
By BCP Investment Corp. · Via GlobeNewswire · November 6, 2025
Data rich period continues to support certepetide’s broad applicability and effectiveness
By Lisata Therapeutics, Inc. · Via GlobeNewswire · November 6, 2025
Delivered Total and Net Investment Income of $36.7 million and $15.7 million, Respectively
By Runway Growth Finance Corp. · Via GlobeNewswire · November 6, 2025
Announces Issuance of $30.0 million Convertible Senior Unsecured Notes due 2031
By Westrock Coffee Company · Via GlobeNewswire · November 6, 2025
ISELIN, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Middlesex Water Company (“Middlesex”) (NASDAQ: MSEX) today announced that Senior Vice President, Chief Financial Officer and Treasurer Rally Zerhouni will present at the Baird 2025 Global Industrial Conference in Chicago on Wednesday, November 12, 2025, at 10:50 a.m. CT (11:50 a.m. ET).
By Middlesex Water Company · Via GlobeNewswire · November 6, 2025
Continuing to explore strategic alternatives focusing on maximizing stockholder value
By Athira Pharma, Inc. · Via GlobeNewswire · November 6, 2025
Continued focused execution of RLY-2608 clinical trials in PI3Kα-mutated breast cancer and vascular malformations
By Relay Therapeutics, Inc. · Via GlobeNewswire · November 6, 2025
Third quarter SaaS revenue of $84.0 million, representing 38% year-over-year growth, 35% on a constant currency basisThird quarter Total revenue of $109.7 million, representing 24% year-over-year growth, 21% on a constant currency basisTotal ARR of $390.0 million, representing 26% year-over-year growth
By AvePoint, Inc. · Via GlobeNewswire · November 6, 2025
Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy in Parkinson’s disease; both advancing toward IND-enabling studies
By Alector, Inc. · Via GlobeNewswire · November 6, 2025
Third Quarter 2025
By TTEC Services Corporation · Via GlobeNewswire · November 6, 2025
SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced third quarter 2025 results, including key performance highlights and market updates, and an update to its 2025 full year outlook.
By WillScot · Via GlobeNewswire · November 6, 2025
Third Quarter Revenue Delivered at High End of Guidance
By Definitive Healthcare Corp. · Via GlobeNewswire · November 6, 2025
WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its first fiscal quarter ended September 30, 2025.
By Ibex Limited · Via GlobeNewswire · November 6, 2025
Q3’25 Marketplace revenue grew 14% YoY to $232 million, above the midpoint of our guidance range
By CarGurus, Inc. · Via GlobeNewswire · November 6, 2025
PALSONIFY™ (Paltusotine) Launched in the U.S. with Encouraging Early Feedback from Patients and Physicians, and Positive Reimbursement Trends
By Crinetics Pharmaceuticals, Inc. · Via GlobeNewswire · November 6, 2025
SAN CLEMENTE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2025.
By ICU Medical, Inc. · Via GlobeNewswire · November 6, 2025
DULUTH, Ga., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today reported financial results for the third fiscal quarter ended October 3, 2025.
By Fox Factory Holding Corp. · Via GlobeNewswire · November 6, 2025
MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Wolfe Research Wealth Symposium on Wednesday, November 12, 2025.
By Robinhood Markets, Inc. · Via GlobeNewswire · November 6, 2025
Board of Directors Declared Total Dividends of $0.50 per Share for Fourth Quarter 2025Base Dividend of $0.43 and Supplemental Dividend of $0.07 Per Share
By Fidus Investment Corporation · Via GlobeNewswire · November 6, 2025
New Structure is Expected to Position the Company to Pursue Sustainable Growth and Long-Term Shareholder Value
By Advanced Flower Capital · Via GlobeNewswire · November 6, 2025
Management to host conference call at 4:15 PM ET, Thursday, November 6, 2025
By Inuvo Inc. · Via GlobeNewswire · November 6, 2025
DENVER, Nov. 06, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended September 30, 2025.
By EverCommerce Inc. · Via GlobeNewswire · November 6, 2025
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial results and provided a business update for the three months ended September 30, 2025.
By Rezolute, Inc. · Via GlobeNewswire · November 6, 2025